Dirui Industrial Co.,Ltd. (300396.SZ)
CNY 13.52
(0.67%)
CNY 13.52
(0.67%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 296.87 Million CNY | -15.75% |
| 2022 | 292.18 Million CNY | 26.97% |
| 2021 | 230.12 Million CNY | -25.65% |
| 2020 | 309.52 Million CNY | 2.05% |
| 2019 | 303.31 Million CNY | 12.87% |
| 2018 | 268.73 Million CNY | 17.12% |
| 2017 | 229.45 Million CNY | 49.08% |
| 2016 | 153.91 Million CNY | 35.08% |
| 2015 | 113.94 Million CNY | 20.43% |
| 2014 | 94.61 Million CNY | 3.0% |
| 2013 | 91.85 Million CNY | 11.64% |
| 2012 | 82.27 Million CNY | 3.97% |
| 2011 | 79.13 Million CNY | 30.22% |
| 2010 | 60.77 Million CNY | 230.79% |
| 2009 | 18.37 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 26.51 Million CNY | -78.35% |
| 2024 Q3 | 31.56 Million CNY | 19.04% |
| 2024 Q1 | 122.5 Million CNY | 1131.75% |
| 2023 Q1 | 85.53 Million CNY | 10.22% |
| 2023 Q3 | 77.26 Million CNY | -17.47% |
| 2023 Q2 | 93.61 Million CNY | 9.45% |
| 2023 FY | 246.15 Million CNY | -15.75% |
| 2023 Q4 | 9.94 Million CNY | -87.13% |
| 2022 Q3 | 67.16 Million CNY | -16.18% |
| 2022 Q2 | 80.13 Million CNY | 19.12% |
| 2022 FY | 292.18 Million CNY | 26.97% |
| 2022 Q4 | 77.6 Million CNY | 15.54% |
| 2022 Q1 | 67.27 Million CNY | 10.76% |
| 2021 Q2 | 53.79 Million CNY | -19.27% |
| 2021 Q1 | 66.63 Million CNY | 85.27% |
| 2021 FY | 230.12 Million CNY | -25.65% |
| 2021 Q4 | 60.73 Million CNY | 24.06% |
| 2021 Q3 | 48.95 Million CNY | -8.99% |
| 2020 Q2 | 87.12 Million CNY | 84.77% |
| 2020 Q4 | 35.96 Million CNY | -74.18% |
| 2020 Q3 | 139.28 Million CNY | 59.87% |
| 2020 FY | 309.52 Million CNY | 2.05% |
| 2020 Q1 | 47.15 Million CNY | -20.16% |
| 2019 Q4 | 59.05 Million CNY | -27.98% |
| 2019 FY | 303.31 Million CNY | 12.87% |
| 2019 Q3 | 82 Million CNY | -16.47% |
| 2019 Q2 | 98.17 Million CNY | 53.2% |
| 2019 Q1 | 64.08 Million CNY | 18.11% |
| 2018 Q2 | 93.73 Million CNY | 81.5% |
| 2018 Q1 | 51.64 Million CNY | 4.04% |
| 2018 FY | 268.73 Million CNY | 17.12% |
| 2018 Q4 | 54.25 Million CNY | -21.48% |
| 2018 Q3 | 69.09 Million CNY | -26.28% |
| 2017 FY | 229.45 Million CNY | 49.08% |
| 2017 Q1 | 38.83 Million CNY | 4.92% |
| 2017 Q2 | 83.63 Million CNY | 115.36% |
| 2017 Q3 | 57.34 Million CNY | -31.44% |
| 2017 Q4 | 49.63 Million CNY | -13.44% |
| 2016 Q3 | 38.32 Million CNY | -25.12% |
| 2016 FY | 153.91 Million CNY | 35.08% |
| 2016 Q1 | 27.39 Million CNY | -33.2% |
| 2016 Q2 | 51.18 Million CNY | 86.87% |
| 2016 Q4 | 37.01 Million CNY | -3.42% |
| 2015 Q3 | 28.9 Million CNY | 2.91% |
| 2015 Q4 | 41 Million CNY | 41.89% |
| 2015 Q2 | 28.08 Million CNY | 76.03% |
| 2015 Q1 | 15.95 Million CNY | -29.14% |
| 2015 FY | 113.94 Million CNY | 20.43% |
| 2014 Q2 | 28.18 Million CNY | 79.02% |
| 2014 Q1 | 15.74 Million CNY | -38.62% |
| 2014 Q4 | 22.51 Million CNY | -20.07% |
| 2014 Q3 | 28.16 Million CNY | -0.07% |
| 2014 FY | 94.61 Million CNY | 3.0% |
| 2013 Q3 | 28.9 Million CNY | 0.0% |
| 2013 FY | 91.85 Million CNY | 11.64% |
| 2013 Q4 | 25.64 Million CNY | -11.26% |
| 2012 FY | 82.27 Million CNY | 3.97% |
| 2011 FY | 79.13 Million CNY | 30.22% |
| 2010 FY | 60.77 Million CNY | 230.79% |
| 2009 FY | 18.37 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 998.13 Million CNY | 70.257% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion CNY | 88.063% |
| Beijing Strong Biotechnologies, Inc. | 593.87 Million CNY | 50.011% |
| Medicalsystem Biotechnology Co., Ltd. | 279.11 Million CNY | -6.362% |
| Maccura Biotechnology Co.Ltd | 331.14 Million CNY | 10.349% |
| Guangzhou Wondfo Biotech Co.,Ltd | 549.13 Million CNY | 45.938% |
| Guangdong Hybribio Biotech Co.,Ltd. | 42.59 Million CNY | -596.892% |
| BGI Genomics Co., Ltd. | 150.64 Million CNY | -97.063% |
| Amoy Diagnostics Co., Ltd. | 301.24 Million CNY | 1.451% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | -135.82 Million CNY | 318.573% |